MARKET

USNA

USNA

Usana Health Sciences Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

69.36
+1.08
+1.58%
After Hours: 69.36 0 0.00% 16:00 05/25 EDT
OPEN
67.70
PREV CLOSE
68.28
HIGH
69.55
LOW
67.15
VOLUME
57.65K
TURNOVER
0
52 WEEK HIGH
107.85
52 WEEK LOW
67.01
MARKET CAP
1.33B
P/E (TTM)
12.82
1D
5D
1M
3M
1Y
5Y
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Simply Wall St. · 1d ago
An Intrinsic Calculation For USANA Health Sciences, Inc. (NYSE:USNA) Suggests It's 32% Undervalued
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of USANA Health Sciences...
Simply Wall St. · 05/10 19:08
During National Mental Health Month, Bestselling Author/CEO Shares 5 Steps for Harmony, Balance
With pandemic-induced anxiety and depression levels increasing by 25 percent globally in 2021 and countries scrambling to support citizens' mental health, one CEO is citing five steps for improved outcomes during National Mental Health Month in May.
PR Newswire · 05/02 11:07
USANA Releases 2021 Sustainability Report
As a global company, USANA is acutely aware of the importance of sustainability and the company's role in taking care of the planet and the people who inhabit it. As part of its investment in sustainability, USANA recently released its second annual sustai...
PR Newswire · 04/28 16:34
DA Davidson Maintains Neutral Rating for Usana Health Sciences: Here's What You Need To Know
DA Davidson has decided to maintain its Neutral rating of Usana Health Sciences (NYSE:USNA) and lower its price target from $86.00 to $76.00. Shares of Usana Health Sciences are trading up 0.89% over the last 24 hours, at $76.19 per share.
Benzinga · 04/27 20:04
--DA Davidson Adjusts USANA Health Sciences' Price Target to $76 from $86, Keeps Neutral Rating
MT Newswires · 04/27 09:22
USANA Health Sciences (USNA) Beats Q1 Earnings and Revenue Estimates
USANA Health (USNA) delivered earnings and revenue surprises of 0.88% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/26 22:35
Recap: Usana Health Sciences Q1 Earnings
Usana Health Sciences (NYSE:USNA) reported its Q1 earnings results on Tuesday, April 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Benzinga · 04/26 21:10
More
No Data
Learn about the latest financial forecast of USNA. Analyze the recent business situations of Usana Health Sciences Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average USNA stock price target is 91.50 with a high estimate of 122.00 and a low estimate of 76.00.
High122.00
Average91.50
Low76.00
Current 69.36
EPS
Actual
Estimate
0.470.941.401.87
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 273
Institutional Holdings: 12.21M
% Owned: 63.61%
Shares Outstanding: 19.19M
TypeInstitutionsShares
Increased
33
612.29K
New
28
166.69K
Decreased
91
694.80K
Sold Out
19
213.02K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
-0.16%
Food & Tobacco
+0.44%
Key Executives
Chairman/Chief Executive Officer/Director
Kevin Guest
President
Jim Brown
Chief Financial Officer
G. Hekking
Chief Operating Officer
Walter Noot
Chief Human Resource Officer
Paul Jones
Chief Marketing Officer
Daniel Macuga
Chief Scientific Officer
Robert Sinnott
General Counsel/Secretary
P. Joshua Foukas
Managing Director
Brent Neidig
Director of Sales
David Mulham
Lead Director/Independent Director
Gilbert Fuller
Independent Director
Xia Ding
Independent Director
John Fleming
Independent Director
Peggie Pelosi
Independent Director
Frederic Winssinger
Independent Director
Timothy Wood
No Data
No Data
About USNA
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Webull offers kinds of USANA Health Sciences, Inc. stock information, including NYSE:USNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, USNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading USNA stock methods without spending real money on the virtual paper trading platform.